US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Aethlon Medical Inc (AEMD)
Aethlon Medical Inc (AEMD) ニュース

AEMD

Aethlon Medical (AEMD)

Aethlon Medical Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AEMD

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/25	02 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2024/05/18	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2024/05/17	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:AEMD	Aethlon Medical Inc
2024/05/17	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:AEMD	Aethlon Medical Inc
2024/05/17	05 : 05	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:AEMD	Aethlon Medical Inc
2024/05/16	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:AEMD	Aethlon Medical Inc
2024/05/15	22 : 27	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:AEMD	Aethlon Medical Inc
2024/05/15	22 : 15	PR Newswire (US)	Aethlon Medical Announces Pricing of $4.7 Million Public Offering	NASDAQ:AEMD	Aethlon Medical Inc
2024/05/14	06 : 30	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:AEMD	Aethlon Medical Inc
2024/05/10	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2024/05/10	21 : 01	PR Newswire (US)	Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma	NASDAQ:AEMD	Aethlon Medical Inc
2024/02/21	22 : 01	PR Newswire (US)	Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices	NASDAQ:AEMD	Aethlon Medical Inc
2024/02/15	07 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AEMD	Aethlon Medical Inc
2024/02/15	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2024/02/15	06 : 15	PR Newswire (US)	Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update	NASDAQ:AEMD	Aethlon Medical Inc
2024/02/07	22 : 00	PR Newswire (US)	Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024	NASDAQ:AEMD	Aethlon Medical Inc
2024/01/03	08 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AEMD	Aethlon Medical Inc
2024/01/03	08 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AEMD	Aethlon Medical Inc
2024/01/03	08 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AEMD	Aethlon Medical Inc
2023/12/23	06 : 01	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:AEMD	Aethlon Medical Inc
2023/11/27	21 : 49	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2023/11/15	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2023/11/15	06 : 15	PR Newswire (US)	Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update	NASDAQ:AEMD	Aethlon Medical Inc
2023/11/13	22 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2023/11/13	22 : 01	PR Newswire (US)	Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer	NASDAQ:AEMD	Aethlon Medical Inc
2023/11/06	22 : 01	PR Newswire (US)	Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023	NASDAQ:AEMD	Aethlon Medical Inc
2023/10/10	21 : 01	PR Newswire (US)	Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology	NASDAQ:AEMD	Aethlon Medical Inc
2023/10/05	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AEMD	Aethlon Medical Inc
2023/10/04	21 : 01	PR Newswire (US)	Aethlon Announces Reverse Stock Split	NASDAQ:AEMD	Aethlon Medical Inc
2023/09/30	06 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AEMD	Aethlon Medical Inc

Showing the most relevant articles for your search:NASDAQ:AEMD

1 2 3 4 5 6 7 8 9 10 次へ >>

IN XT.MSCI EUR.HDY ESG EO

NLBNPIT1ZBF5 20240920 850

Queensland Treasury

Credit Agricole CIB Fina...

NLBNPIT1ZJ02 20240918 44...

Btp Tf 3,4% Ap28 Eur

Banque Stellantis 4000% ...

SavePlanetEarth

Manitex Capital

Credit Agricole Sa null

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約